{"nctId":"NCT00808132","briefTitle":"Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis","startDateStruct":{"date":"2009-01"},"conditions":["Menopause","Osteoporosis"],"count":1886,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: bazedoxifene 20 mg/ conjugated estrogens 0.45 mg"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: bazedoxifene 20 mg/ conjugated estrogens 0.625 mg"]},{"label":"3","type":"EXPERIMENTAL","interventionNames":["Drug: bazedoxifene 20 mg"]},{"label":"4","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: conjugated estrogens 0.45 mg/ medroxyprogesterone acetate 1.5 mg"]},{"label":"5","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"bazedoxifene 20 mg/ conjugated estrogens 0.45 mg","otherNames":[]},{"name":"bazedoxifene 20 mg/ conjugated estrogens 0.625 mg","otherNames":[]},{"name":"bazedoxifene 20 mg","otherNames":[]},{"name":"conjugated estrogens 0.45 mg/ medroxyprogesterone acetate 1.5 mg","otherNames":["Prempro"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Generally healthy, postmenopausal women, aged 40 to 64 seeking treatment for menopausal symptoms\n* At least 12 months of spontaneous amenorrhea, OR 6 months spontaneous amenorrhea with follicle-stimulating hormone (FSH) levels \\> 40 mIU/mL\n* Intact Uterus\n\nExclusion Criteria:\n\n* Use of oral estrogen, progestin, androgen, or selective estrogen receptor modulator (SERM) containing drug products within 8 weeks before screening\n* A history or active presence of clinically important medical disease: eg. cardiovascular disease (stroke, heart attack), chronic renal or liver disease, breast cancer, etc.","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"40 Years","maximumAge":"64 Years","stdAges":["ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Participants With Endometrial Hyperplasia at Month 12: Main Study","description":"Endometrial hyperplasia was assessed by endometrial biopsies. All endometrial biopsies were read centrally by 2 primary pathologists. If both the pathologists disagreed on the presence of hyperplasia, a third pathologist was consulted. Results were summarized for two definitions of hyperplasia (simple hyperplasia with or without atypia or complex hyperplasia with or without atypia); definition 1: participants were considered to have a diagnosis of hyperplasia when the 3 pathologists disagreed but at least 1 pathologist determined hyperplasia; definition 2: participants were considered to have a diagnosis of hyperplasia if at least 2 of the 3 pathologists agreed on the diagnosis.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.30","spread":null},{"groupId":"OG001","value":"0.54","spread":null},{"groupId":"OG002","value":"0.00","spread":null},{"groupId":"OG003","value":"0.00","spread":null},{"groupId":"OG004","value":"0.85","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.30","spread":null},{"groupId":"OG001","value":"0.27","spread":null},{"groupId":"OG002","value":"0.00","spread":null},{"groupId":"OG003","value":"0.00","spread":null},{"groupId":"OG004","value":"0.28","spread":null}]}]}]},{"type":"PRIMARY","title":"Percent Change From Baseline in Bone Mineral Density (BMD) of Lumbar Spine at Month 12: Osteoporosis Sub-Study","description":"BMD measurements of the anteroposterior lumbar spine were acquired by using dual-energy x-ray absorptiometry (DXA) scans, twice at Month 12 for a subset of participants who entered the osteoporosis substudy. The second scan was to be performed on the same day as the first; however, the participant was to be removed completely from the table after the first scan and repositioned for the second scan. Mean percentage change from baseline of the 2 readings were reported.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.24","spread":"0.29"},{"groupId":"OG001","value":"0.60","spread":"0.27"},{"groupId":"OG002","value":"0.07","spread":"0.40"},{"groupId":"OG003","value":"1.30","spread":"0.39"},{"groupId":"OG004","value":"-1.28","spread":"0.28"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Bone Mineral Density (BMD) of Lumbar Spine at Month 6: Osteoporosis Sub-Study","description":"BMD measurements of the anteroposterior lumbar spine were acquired by using DXA scans, twice at Month 6 for a subset of participants who entered the osteoporosis substudy. The second scan was to be performed on the same day as the first; however, the participant was to be removed completely from the table after the first scan and repositioned for the second scan. Mean percentage change from baseline of the 2 readings were reported.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.12","spread":"0.28"},{"groupId":"OG001","value":"0.51","spread":"0.26"},{"groupId":"OG002","value":"0.00","spread":"0.39"},{"groupId":"OG003","value":"0.64","spread":"0.37"},{"groupId":"OG004","value":"-0.68","spread":"0.27"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Bone Mineral Density (BMD) of Total Hip at Month 6, 12: Osteoporosis Sub-Study","description":"BMD measurements of the total hip were acquired by using DXA scans, twice at Month 6 and 12 for a subset of participants who entered the osteoporosis substudy. The second scan was to be performed on the same day as the first; however, the participant was to be removed completely from the table after the first scan and repositioned for the second scan. Mean percentage change from baseline of the 2 readings were reported.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.43","spread":"0.18"},{"groupId":"OG001","value":"0.66","spread":"0.17"},{"groupId":"OG002","value":"0.32","spread":"0.25"},{"groupId":"OG003","value":"0.45","spread":"0.24"},{"groupId":"OG004","value":"-0.90","spread":"0.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.50","spread":"0.20"},{"groupId":"OG001","value":"0.89","spread":"0.18"},{"groupId":"OG002","value":"0.47","spread":"0.27"},{"groupId":"OG003","value":"0.71","spread":"0.26"},{"groupId":"OG004","value":"-0.72","spread":"0.18"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Cumulative Amenorrhea: Main Study","description":"Cumulative amenorrhea was defined as the absence of any bleeding or spotting for cumulative 4-week periods throughout 1-year study.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"87.89","spread":null},{"groupId":"OG001","value":"84.87","spread":null},{"groupId":"OG002","value":"82.35","spread":null},{"groupId":"OG003","value":"54.43","spread":null},{"groupId":"OG004","value":"83.91","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Breast Density at Month 12: Breast Density Sub-Study","description":"Breast density was assessed by digitalized mammograms which were centrally read by a single radiologist using specifically-developed software. Breast density was assessed for subset of participants who entered the breast density sub-study","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.38","spread":"0.22"},{"groupId":"OG001","value":"-0.45","spread":"0.22"},{"groupId":"OG002","value":"-0.25","spread":"0.30"},{"groupId":"OG003","value":"1.60","spread":"0.35"},{"groupId":"OG004","value":"-0.32","spread":"0.23"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Bone Turnover Markers (BTMs) at Month 6 and Month 12: Osteoporosis Sub-Study","description":"Bone turnover is the removal of old bone from the body and its replacement by new bone. Bone turnover markers included serum osteocalcin, C-telopeptide, and procollagen type 1 N-propeptide (P1NP), were measured at Month 6 and Month 12 for a subset of participants who entered the osteoporosis substudy. Blood samples were collected to evaluate bone turnover markers levels.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-25.21","spread":null},{"groupId":"OG001","value":"-27.79","spread":null},{"groupId":"OG002","value":"-15.60","spread":null},{"groupId":"OG003","value":"-25.34","spread":null},{"groupId":"OG004","value":"-3.19","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-30.46","spread":null},{"groupId":"OG001","value":"-37.02","spread":null},{"groupId":"OG002","value":"-16.05","spread":null},{"groupId":"OG003","value":"-32.79","spread":null},{"groupId":"OG004","value":"-5.28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-34.16","spread":null},{"groupId":"OG001","value":"-41.41","spread":null},{"groupId":"OG002","value":"-29.37","spread":null},{"groupId":"OG003","value":"-54.05","spread":null},{"groupId":"OG004","value":"-10.17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-40.86","spread":null},{"groupId":"OG001","value":"-50.06","spread":null},{"groupId":"OG002","value":"-27.39","spread":null},{"groupId":"OG003","value":"-52.56","spread":null},{"groupId":"OG004","value":"-5.52","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-33.73","spread":null},{"groupId":"OG001","value":"-30.26","spread":null},{"groupId":"OG002","value":"-17.38","spread":null},{"groupId":"OG003","value":"-39.99","spread":null},{"groupId":"OG004","value":"5.99","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-42.38","spread":null},{"groupId":"OG001","value":"-43.58","spread":null},{"groupId":"OG002","value":"-23.97","spread":null},{"groupId":"OG003","value":"-50.19","spread":null},{"groupId":"OG004","value":"-11.13","spread":null}]}]}]},{"type":"SECONDARY","title":"Medical Outcomes Study (MOS) Sleep Scale at Baseline: Sleep Sub-Study","description":"Participant-rated questionnaire to assess sleep quality and quantity. Consists of 12-item questionnaires answered on a range of 1 to 6 for questions (Q) 3 to 12, 1 to 5 for Q1 (some questions are reversed so that a high score reflects more of the attributes); and Q2 answered on 0 to 24. Scores are transformed (actual raw score minus lowest possible score divided by possible raw score range\\* 100); total score range: 0 to 100; higher score = greater intensity of attribute. The items contribute to each scale and are averaged to create the 7 scale scores and a sleep quantity scale. Scales with at least one item answered was used to generate a scale score. Scales include; sleep disturbance (SD), snoring, awaken short of breath (ASoB) or with a headache (H), somnolence, sleep adequacy (SA), sleep problem index (SPI) I and II (range: 0-100) and sleep quantity (SQ \\[range 0 to 24\\]). Except for sleep quantity, higher scores=greater impairment.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"48.9","spread":"22.9"},{"groupId":"OG001","value":"48.2","spread":"21.7"},{"groupId":"OG002","value":"50.5","spread":"24.4"},{"groupId":"OG003","value":"50.4","spread":"21.1"},{"groupId":"OG004","value":"47.8","spread":"24.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32.1","spread":"30.1"},{"groupId":"OG001","value":"27.6","spread":"26.9"},{"groupId":"OG002","value":"37.9","spread":"30.7"},{"groupId":"OG003","value":"33.1","spread":"29.6"},{"groupId":"OG004","value":"34.4","spread":"30.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.5","spread":"19.2"},{"groupId":"OG001","value":"11.9","spread":"19.4"},{"groupId":"OG002","value":"13.2","spread":"20.1"},{"groupId":"OG003","value":"13.1","spread":"20.2"},{"groupId":"OG004","value":"12.1","spread":"20.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.3","spread":"21.6"},{"groupId":"OG001","value":"30.0","spread":"20.1"},{"groupId":"OG002","value":"34.6","spread":"23.5"},{"groupId":"OG003","value":"28.7","spread":"19.4"},{"groupId":"OG004","value":"31.2","spread":"19.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.3","spread":"24.3"},{"groupId":"OG001","value":"41.7","spread":"23.9"},{"groupId":"OG002","value":"37.4","spread":"23.2"},{"groupId":"OG003","value":"36.5","spread":"20.6"},{"groupId":"OG004","value":"40.3","spread":"23.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"44.5","spread":"17.3"},{"groupId":"OG001","value":"42.0","spread":"16.7"},{"groupId":"OG002","value":"44.7","spread":"18.2"},{"groupId":"OG003","value":"44.9","spread":"16.0"},{"groupId":"OG004","value":"43.4","spread":"18.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"45.5","spread":"17.2"},{"groupId":"OG001","value":"43.2","spread":"16.8"},{"groupId":"OG002","value":"46.4","spread":"18.0"},{"groupId":"OG003","value":"45.2","spread":"16.1"},{"groupId":"OG004","value":"43.7","spread":"18.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.2","spread":"1.1"},{"groupId":"OG001","value":"6.1","spread":"1.1"},{"groupId":"OG002","value":"5.9","spread":"1.1"},{"groupId":"OG003","value":"6.2","spread":"1.3"},{"groupId":"OG004","value":"6.2","spread":"1.1"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants With Breast Tenderness","description":"Percentage of participants who reported at least 1 day of breast tenderness during each 4-week period for 1-year on therapy was calculated.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.29","spread":null},{"groupId":"OG001","value":"6.46","spread":null},{"groupId":"OG002","value":"4.55","spread":null},{"groupId":"OG003","value":"7.28","spread":null},{"groupId":"OG004","value":"6.56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.39","spread":null},{"groupId":"OG001","value":"9.13","spread":null},{"groupId":"OG002","value":"5.91","spread":null},{"groupId":"OG003","value":"20.49","spread":null},{"groupId":"OG004","value":"8.32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.04","spread":null},{"groupId":"OG001","value":"6.94","spread":null},{"groupId":"OG002","value":"7.87","spread":null},{"groupId":"OG003","value":"24.26","spread":null},{"groupId":"OG004","value":"8.55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.83","spread":null},{"groupId":"OG001","value":"7.97","spread":null},{"groupId":"OG002","value":"6.60","spread":null},{"groupId":"OG003","value":"23.98","spread":null},{"groupId":"OG004","value":"5.37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.06","spread":null},{"groupId":"OG001","value":"8.31","spread":null},{"groupId":"OG002","value":"8.65","spread":null},{"groupId":"OG003","value":"21.24","spread":null},{"groupId":"OG004","value":"5.91","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.05","spread":null},{"groupId":"OG001","value":"4.37","spread":null},{"groupId":"OG002","value":"6.09","spread":null},{"groupId":"OG003","value":"17.13","spread":null},{"groupId":"OG004","value":"4.29","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.60","spread":null},{"groupId":"OG001","value":"3.90","spread":null},{"groupId":"OG002","value":"5.64","spread":null},{"groupId":"OG003","value":"15.00","spread":null},{"groupId":"OG004","value":"4.33","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.08","spread":null},{"groupId":"OG001","value":"5.62","spread":null},{"groupId":"OG002","value":"4.15","spread":null},{"groupId":"OG003","value":"15.64","spread":null},{"groupId":"OG004","value":"4.09","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.57","spread":null},{"groupId":"OG001","value":"3.97","spread":null},{"groupId":"OG002","value":"1.58","spread":null},{"groupId":"OG003","value":"15.20","spread":null},{"groupId":"OG004","value":"2.00","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.98","spread":null},{"groupId":"OG001","value":"3.49","spread":null},{"groupId":"OG002","value":"3.19","spread":null},{"groupId":"OG003","value":"12.50","spread":null},{"groupId":"OG004","value":"2.28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.07","spread":null},{"groupId":"OG001","value":"4.01","spread":null},{"groupId":"OG002","value":"2.67","spread":null},{"groupId":"OG003","value":"12.05","spread":null},{"groupId":"OG004","value":"3.08","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.62","spread":null},{"groupId":"OG001","value":"2.60","spread":null},{"groupId":"OG002","value":"1.63","spread":null},{"groupId":"OG003","value":"9.43","spread":null},{"groupId":"OG004","value":"2.62","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.67","spread":null},{"groupId":"OG001","value":"3.14","spread":null},{"groupId":"OG002","value":"2.17","spread":null},{"groupId":"OG003","value":"10.83","spread":null},{"groupId":"OG004","value":"3.17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.12","spread":null},{"groupId":"OG001","value":"2.89","spread":null},{"groupId":"OG002","value":"1.64","spread":null},{"groupId":"OG003","value":"9.62","spread":null},{"groupId":"OG004","value":"2.66","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Medical Outcomes Study (MOS) Sleep Scale at Month 3: Sleep Sub-Study","description":"Participant-rated questionnaire to assess sleep quality and quantity. Consists of 12-item questionnaires answered on a range of 1 to 6 for questions (Q) 3 to 12, 1 to 5 for Q1 (some questions are reversed so that a high score reflects more of the attributes); and Q2 answered on 0 to 24. Scores are transformed (actual raw score minus lowest possible score divided by possible raw score range\\* 100); total score range: 0 to 100; higher score = greater intensity of attribute. The items contribute to each scale and are averaged to create the 7 scale scores and a sleep quantity scale. Scales with at least one item answered was used to generate a scale score. Scales include; sleep disturbance (SD), snoring, awaken short of breath (ASoB) or with a headache (H), somnolence, sleep adequacy (SA), sleep problem index (SPI) I and II (range: 0-100) and sleep quantity (SQ \\[range 0 to 24\\]). Except for sleep quantity, higher scores=greater impairment.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.27","spread":"2.01"},{"groupId":"OG001","value":"-18.18","spread":"1.94"},{"groupId":"OG002","value":"-11.64","spread":"2.94"},{"groupId":"OG003","value":"-18.01","spread":"2.79"},{"groupId":"OG004","value":"-14.34","spread":"2.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.86","spread":"1.83"},{"groupId":"OG001","value":"-5.38","spread":"1.76"},{"groupId":"OG002","value":"-2.54","spread":"2.67"},{"groupId":"OG003","value":"-2.90","spread":"2.55"},{"groupId":"OG004","value":"-2.71","spread":"1.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.26","spread":"1.41"},{"groupId":"OG001","value":"-5.81","spread":"1.35"},{"groupId":"OG002","value":"-3.12","spread":"2.06"},{"groupId":"OG003","value":"-3.62","spread":"1.95"},{"groupId":"OG004","value":"-3.63","spread":"1.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.54","spread":"1.53"},{"groupId":"OG001","value":"-9.72","spread":"1.48"},{"groupId":"OG002","value":"-6.12","spread":"2.25"},{"groupId":"OG003","value":"-7.36","spread":"2.14"},{"groupId":"OG004","value":"-10.55","spread":"1.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.22","spread":"2.40"},{"groupId":"OG001","value":"14.30","spread":"2.32"},{"groupId":"OG002","value":"9.10","spread":"3.52"},{"groupId":"OG003","value":"15.10","spread":"3.34"},{"groupId":"OG004","value":"11.46","spread":"2.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.19","spread":"1.51"},{"groupId":"OG001","value":"-13.99","spread":"1.46"},{"groupId":"OG002","value":"-8.92","spread":"2.21"},{"groupId":"OG003","value":"-13.71","spread":"2.09"},{"groupId":"OG004","value":"-11.84","spread":"1.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.01","spread":"1.51"},{"groupId":"OG001","value":"-14.53","spread":"1.46"},{"groupId":"OG002","value":"-9.64","spread":"2.21"},{"groupId":"OG003","value":"-14.12","spread":"2.10"},{"groupId":"OG004","value":"-12.04","spread":"1.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.28","spread":"0.10"},{"groupId":"OG001","value":"0.44","spread":"0.09"},{"groupId":"OG002","value":"0.32","spread":"0.14"},{"groupId":"OG003","value":"0.41","spread":"0.13"},{"groupId":"OG004","value":"0.36","spread":"0.10"}]}]}]},{"type":"SECONDARY","title":"Menopause-Specific Quality of Life (MENQOL) Score at Baseline: Sleep Sub-Study","description":"MENQOL questionnaire assessed how bothered participants were due to menopause. It consists of 29 items divided into 4 domains: vasomotor function (3 items), psychosocial function (7 items), physical function (16 items), and sexual function (3 items). Each item scores a range from 1 to 8, with 1 indicating that the participant did not experience the symptom or problem, 8 indicating that the participant was extremely bothered by the symptom or problem. The total score for each domain is the average of item scores and ranged from 1 to 8 with higher score indicating worsening of symptoms. The MENQOL total score is the mean of these 4 domain scores and ranged from 1 to 8 with higher score indicating worsening of symptoms.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.40","spread":"1.564"},{"groupId":"OG001","value":"5.60","spread":"1.468"},{"groupId":"OG002","value":"5.87","spread":"1.246"},{"groupId":"OG003","value":"5.65","spread":"1.620"},{"groupId":"OG004","value":"5.62","spread":"1.596"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.46","spread":"1.716"},{"groupId":"OG001","value":"3.41","spread":"1.628"},{"groupId":"OG002","value":"3.49","spread":"1.663"},{"groupId":"OG003","value":"3.48","spread":"1.793"},{"groupId":"OG004","value":"3.22","spread":"1.522"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.74","spread":"1.377"},{"groupId":"OG001","value":"3.58","spread":"1.385"},{"groupId":"OG002","value":"3.96","spread":"1.475"},{"groupId":"OG003","value":"3.74","spread":"1.409"},{"groupId":"OG004","value":"3.58","spread":"1.445"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.74","spread":"2.200"},{"groupId":"OG001","value":"3.63","spread":"2.182"},{"groupId":"OG002","value":"4.05","spread":"2.265"},{"groupId":"OG003","value":"3.73","spread":"2.238"},{"groupId":"OG004","value":"3.83","spread":"2.243"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.07","spread":"1.227"},{"groupId":"OG001","value":"4.05","spread":"1.246"},{"groupId":"OG002","value":"4.34","spread":"1.156"},{"groupId":"OG003","value":"4.15","spread":"1.314"},{"groupId":"OG004","value":"4.06","spread":"1.155"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Menopause-Specific Quality of Life (MENQOL) Score at Month 3: Sleep Sub-Study","description":"MENQOL questionnaire assessed how bothered participants were due to menopause. It consists of 29 items divided into 4 domains: vasomotor function (3 items), psychosocial function (7 items), physical function (16 items), and sexual function (3 items). Each item scores a range from 1 to 8, with 1 indicating that the participant did not experience the symptom or problem, 8 indicating that the participant was extremely bothered by the symptom or problem. The total score for each domain is the average of item scores and ranged from 1 to 8 with higher score indicating worsening of symptoms. The MENQOL total score is the mean of these 4 domain scores and ranged from 1 to 8 with higher score indicating worsening of symptoms.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.37","spread":"0.17"},{"groupId":"OG001","value":"-2.75","spread":"0.17"},{"groupId":"OG002","value":"-1.25","spread":"0.25"},{"groupId":"OG003","value":"-3.19","spread":"0.24"},{"groupId":"OG004","value":"-1.45","spread":"0.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.67","spread":"0.12"},{"groupId":"OG001","value":"-0.84","spread":"0.12"},{"groupId":"OG002","value":"-0.47","spread":"0.18"},{"groupId":"OG003","value":"-0.83","spread":"0.17"},{"groupId":"OG004","value":"-0.74","spread":"0.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.92","spread":"0.10"},{"groupId":"OG001","value":"-1.11","spread":"0.10"},{"groupId":"OG002","value":"-0.67","spread":"0.15"},{"groupId":"OG003","value":"-0.76","spread":"0.14"},{"groupId":"OG004","value":"-0.87","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.20","spread":"0.16"},{"groupId":"OG001","value":"-1.40","spread":"0.15"},{"groupId":"OG002","value":"-0.09","spread":"0.23"},{"groupId":"OG003","value":"-0.76","spread":"0.22"},{"groupId":"OG004","value":"-1.04","spread":"0.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.27","spread":"0.10"},{"groupId":"OG001","value":"-1.53","spread":"0.10"},{"groupId":"OG002","value":"-0.63","spread":"0.15"},{"groupId":"OG003","value":"-1.39","spread":"0.14"},{"groupId":"OG004","value":"-1.03","spread":"0.10"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Uterine Bleeding","description":"Percentage of participants with uterine bleeding were calculated for each 4-week period for 1-year on therapy.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.86","spread":null},{"groupId":"OG001","value":"6.20","spread":null},{"groupId":"OG002","value":"5.68","spread":null},{"groupId":"OG003","value":"20.83","spread":null},{"groupId":"OG004","value":"4.68","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.44","spread":null},{"groupId":"OG001","value":"5.02","spread":null},{"groupId":"OG002","value":"3.62","spread":null},{"groupId":"OG003","value":"24.39","spread":null},{"groupId":"OG004","value":"4.11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.16","spread":null},{"groupId":"OG001","value":"3.55","spread":null},{"groupId":"OG002","value":"2.76","spread":null},{"groupId":"OG003","value":"25.63","spread":null},{"groupId":"OG004","value":"4.42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.41","spread":null},{"groupId":"OG001","value":"2.91","spread":null},{"groupId":"OG002","value":"3.29","spread":null},{"groupId":"OG003","value":"24.49","spread":null},{"groupId":"OG004","value":"3.36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.26","spread":null},{"groupId":"OG001","value":"2.58","spread":null},{"groupId":"OG002","value":"2.49","spread":null},{"groupId":"OG003","value":"18.48","spread":null},{"groupId":"OG004","value":"3.51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.78","spread":null},{"groupId":"OG001","value":"2.12","spread":null},{"groupId":"OG002","value":"2.01","spread":null},{"groupId":"OG003","value":"18.58","spread":null},{"groupId":"OG004","value":"3.31","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.04","spread":null},{"groupId":"OG001","value":"2.13","spread":null},{"groupId":"OG002","value":"1.02","spread":null},{"groupId":"OG003","value":"14.84","spread":null},{"groupId":"OG004","value":"3.33","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.60","spread":null},{"groupId":"OG001","value":"1.68","spread":null},{"groupId":"OG002","value":"1.55","spread":null},{"groupId":"OG003","value":"12.14","spread":null},{"groupId":"OG004","value":"1.73","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.54","spread":null},{"groupId":"OG001","value":"2.91","spread":null},{"groupId":"OG002","value":"2.08","spread":null},{"groupId":"OG003","value":"12.94","spread":null},{"groupId":"OG004","value":"2.26","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.61","spread":null},{"groupId":"OG001","value":"2.92","spread":null},{"groupId":"OG002","value":"1.57","spread":null},{"groupId":"OG003","value":"14.29","spread":null},{"groupId":"OG004","value":"4.82","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.38","spread":null},{"groupId":"OG001","value":"1.26","spread":null},{"groupId":"OG002","value":"0.00","spread":null},{"groupId":"OG003","value":"13.58","spread":null},{"groupId":"OG004","value":"1.55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.84","spread":null},{"groupId":"OG001","value":"2.28","spread":null},{"groupId":"OG002","value":"0.53","spread":null},{"groupId":"OG003","value":"14.38","spread":null},{"groupId":"OG004","value":"2.09","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.68","spread":null},{"groupId":"OG001","value":"1.28","spread":null},{"groupId":"OG002","value":"1.07","spread":null},{"groupId":"OG003","value":"8.81","spread":null},{"groupId":"OG004","value":"1.58","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":16,"n":445},"commonTop":["Headache","Nasopharyngitis","Back pain","Pain in extremity","Arthralgia"]}}}